Molecular and cytogenetic studies strongly implicate the plasticity of the cancer cell genome in malignant progression. Gene amplification is one prominent example of this genetic flexibility which is peculiar to malignant cells. The overexpression of proto oncogenes mediated by gene amplification has now been described in a variety of tumors of human and rodent origin, and in some cases it has been shown how such overproduction can engender increased invasiveness, ability to evade immune surveillance, etc. In addition, there is now ample documentation in human tumors in vivo that gene amplification can lead to resistance to a variety of antineoplastic agents alone, or in combination. Therefore, understanding the mechanisms of gene amplification could lead to a better understanding of how the control mechanisms which insure genetic stability in normal cells are abrogated in cancer cells, and the types of conditions which favor the occurrence of the amplification process. Such information could lead to new strategies of drug delivery to avoid development of resistance by this mechanism. This proposal presents experiments to investigate the nature of the earliest molecular products produced by gene amplification. Specifically, it will be tested whether submicroscopic, autonomously replicating circular elements are commonly generated as a first step. This hypothesis is formulated on the basis of previous work from this laboratory which demonstrated that such elements can be precursors of minute chromosomes. The structure of such elements will be analyzed using physical and molecular cloning methods designed to study genetic regions spanning hundreds of kilobases, and the hypothesis that such elements comprise functional replication domains will be tested. A replication origin present in one such element described previously in this lab will be isolated and analyzed in order to deduce how its structure contributes to regulated replication. Finally, a gene transfer method is proposed for identifying regions of the human genome associated with the capacity for high frequency gene amplication. By analogy with previous results from this lab, this approach could enable isolation of a human replication origin for further molecular characterization.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
9R01CA061449-14
Application #
3204862
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1993-07-01
Project End
1996-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
14
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
He, Guifen; Zhang, Yi-Wei; Lee, Jun-Ho et al. (2014) AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity. Mol Cell Biol 34:148-57
Li, Yao-Cheng; Rodewald, Luo Wei; Hoppmann, Christian et al. (2014) A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time. Cell Rep 9:1946-1958
Wade, Mark; Li, Yao-Cheng; Wahl, Geoffrey M (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13:83-96
Wade, M; Li, Y C; Matani, A S et al. (2012) Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells. Oncogene 31:4789-97
Lee, Jun-Ho; Jin, Yetao; He, Guifen et al. (2012) Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3? inactivation of MDMX protein. J Biol Chem 287:20898-903
Wang, Yunyuan V; Leblanc, Mathias; Fox, Norma et al. (2011) Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev 25:1426-38
Bernal, Federico; Wade, Mark; Godes, Marina et al. (2010) A stapled p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell 18:411-22
Wade, Mark; Wang, Yunyuan V; Wahl, Geoffrey M (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 20:299-309
Mizuno, Hideaki; Spike, Benjamin T; Wahl, Geoffrey M et al. (2010) Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci U S A 107:22745-50
Wang, Yunyuan V; Wade, Mark; Wahl, Geoffrey M (2009) Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo. Cell Cycle 8:3443-4

Showing the most recent 10 out of 28 publications